The DOI matches its Crossref record; 31 of the 31 references it cites were found in a registry or an index.
Estimating Prevalence of Hepatitis C Virus Infection in the United States, 2013‐2016
Open accessAbstract
Hepatitis C virus (HCV) infection is the most commonly reported bloodborne infection in the United States, causing substantial morbidity and mortality and costing billions of dollars annually. To update the estimated HCV prevalence among all adults aged ≥18 years in the United States, we analyzed 2013‐2016 data from the National Health and Nutrition Examination Survey (NHANES) to estimate the prevalence of HCV in the noninstitutionalized civilian population and used a combination of literature reviews and population size estimation approaches to estimate the HCV prevalence and population sizes for four additional populations: incarcerated people, unsheltered homeless people, active‐duty military personnel, and nursing home residents. We estimated that during 2013‐2016 1.7% (95% confidence interval [CI], 1.4‐2.0%) of all adults in the United States, approximately 4.1 (3.4‐4.9) million persons, were HCV antibody‐positive (indicating past or current infection) and that 1.0% (95% CI, 0.8‐1.1%) of all adults, approximately 2.4 (2.0‐2.8) million persons, were HCV RNA–positive (indicating current infection). This includes 3.7 million noninstitutionalized civilian adults in the United States with HCV antibodies and 2.1 million with HCV RNA and an estimated 0.38 million HCV antibody‐positive persons and 0.25 million HCV RNA–positive persons not part of the 2013‐2016 NHANES sampling frame. Conclusion: Over 2 million people in the United States had current HCV infection during 2013‐2016; compared to past estimates based on similar methodology, HCV antibody prevalence may have increased, while RNA prevalence may have decreased, likely reflecting the combination of the opioid crisis, curative treatment for HCV infection, and mortality among the HCV‐infected population; efforts on multiple fronts are needed to combat the evolving HCV epidemic, including increasing capacity for and access to HCV testing, linkage to care, and cure.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Ledipasvir and Sofosbuvir for Untreated HCV Genotype 1 Infection
Afdhal, N., Zeuzem, S., Kwo, P., Chojkier, M., Gitlin, N., Puoti, M., Romero-Gomez, M., Zarski, J.-P., Agarwal, K., Buggisch, P., et al. (2014) · New England Journal of Medicine · doi:10.1056/nejmoa1402454 · Cited by 1,705
Peginterferon Alfa-2b or Alfa-2a with Ribavirin for Treatment of Hepatitis C Infection
McHutchison, J. G., Lawitz, E. J., Shiffman, M. L., Muir, A. J., Galler, G. W., McCone, J., Nyberg, L. M., Lee, W. M., Ghalib, R. H., Schiff, E. R., et al. (2009) · New England Journal of Medicine · doi:10.1056/nejmoa0808010 · Cited by 1,190
National health and nutrition examination survey: sample design, 2011-2014.
Johnson, C. L., Dohrmann, S. M., Burt, V. L., & Mohadjer, L. K. (2014) · PubMed · Cited by 1,089
Natural history of hepatitis C.
Westbrook, R. H., & Dusheiko, G. (2014) · Journal of Hepatology · doi:10.1016/j.jhep.2014.07.012 · Cited by 1,049
Smith, B. D., Morgan, R. L., Beckett, G. A., Falck-Ytter, Y. T., Holtzman, D. J., Teo, C., Jewett, A., Baack, B. N., Rein, D. B., Patel, N., et al. (2012) · PubMed · Cited by 991
Self-citationMicallef, J. M., Kaldor, J. M., & Dore, G. J. (2006) · Journal of Viral Hepatitis · doi:10.1111/j.1365-2893.2005.00651.x · Cited by 871
Denniston, M. M., Jiles, R. B., Drobeniuc, J., Klevens, R. M., Ward, J. W., McQuillan, G. M., & Holmberg, S. D. (2014) · Annals of Internal Medicine · doi:10.7326/m13-1133 · Cited by 724
Self-citationZibbell, J. E., Asher, A. K., Patel, R. C., Kupronis, B., Iqbal, K., Ward, J. W., & Holtzman, D. (2018) · American Journal of Public Health · doi:10.2105/ajph.2017.304132 · Cited by 698
Self-citationABT-450/r–Ombitasvir and Dasabuvir with or without Ribavirin for HCV
Ferenci, P., Bernstein, D., Lalezari, J., Cohen, D., Luo, Y., Cooper, C., Tam, E., Marinho, R. T., Tsai, N., Nyberg, A., et al. (2014) · New England Journal of Medicine · doi:10.1056/nejmoa1402338 · Cited by 693
Harris-Kojetin, L. (2016) · PubMed · doi:10.13140/rg.2.1.1207.6407 · Cited by 688
The National Health and Nutrition Examination Survey: Sample Design, 1999-2006.
Curtin, L. R., Mohadjer, L. K., Dohrmann, S. M., Montaquila, J. M., Kruszan-Moran, D., Mirel, L. B., Carroll, M. D., Hirsch, R., Schober, S. E., & Johnson, C. L. (2012) · PubMed · Cited by 656
Zibbell, J. E., Iqbal, K., Patel, R. C., Suryaprasad, A. G., Sanders, K. J., Moore-Moravian, L., Serrecchia, J., Blankenship, S., Ward, J. W., & Holtzman, D. J. (2015) · PubMed Central · Cited by 507
Self-citationSuryaprasad, A. G., White, J. Z., Xu, F., Eichler, B.-A., Hamilton, J., Patel, A., Hamdounia, S. B., Church, D. R., Barton, K., Fisher, C., et al. (2014) · Clinical Infectious Diseases · doi:10.1093/cid/ciu643 · Cited by 500
Self-citationYehia, B. R., Schranz, A. J., Umscheid, C. A., & Lo Re, V. (2014) · PLoS ONE · doi:10.1371/journal.pone.0101554 · Cited by 440
Toward a more accurate estimate of the prevalence of hepatitis C in the United States
Edlin, B. R., Eckhardt, B. J., Shu, M. A., Holmberg, S. D., & Swan, T. (2015) · Hepatology · doi:10.1002/hep.27978 · Cited by 433
Self-citationNatural History of Hepatitis C
Thomas, D. L., & Seeff, L. B. (2005) · Clinics in Liver Disease · doi:10.1016/j.cld.2005.05.003 · Cited by 402
OPTN/SRTR 2016 Annual Data Report: Liver
Kim, W. R., Lake, J. R., Smith, J. M., Schladt, D. P., Skeans, M. A., Harper, A. M., Wainright, J. L., Snyder, J. J., Israni, A. K., & Kasiske, B. L. (2018) · American Journal of Transplantation · doi:10.1111/ajt.14559 · Cited by 401
Hepatitis C virus infection in USA: an estimate of true prevalence
Chak, E., Talal, A. H., Sherman, K. E., Schiff, E. R., & Saab, S. (2011) · Liver International · doi:10.1111/j.1478-3231.2011.02494.x · Cited by 396
Denniston, M. M., Klevens, M. R., McQuillan, G. M., & Jiles, R. B. (2012) · Hepatology · doi:10.1002/hep.25556 · Cited by 378
Rising mortality associated with hepatitis C virus in the United States, 2003–2013
Ly, K. N., Hughes, E. M., Jiles, R. B., & Holmberg, S. D. (2016) · Clinical Infectious Diseases · doi:10.1093/cid/ciw111 · Cited by 358
Testing for HCV Infection: An Update of Guidance for Clinicians and Laboratorians
Getchell, J. P., Wroblewski, K., DeMaria, A., et al. (2013) · PubMed Central · Cited by 325
Testing for HCV infection: an update of guidance for clinicians and laboratorians.
(2013) · PubMed · Cited by 145
Koneru, A., Nelson, N. P., Hariri, S., Canary, L., Sanders, K. J., Maxwell, J. F., Huang, X., Leake, J. A. D., Ward, J. W., & Vellozzi, C. J. (2016) · MMWR Morbidity and Mortality Weekly Report · doi:10.15585/mmwr.mm6528a2 · Cited by 138
Self-citationBelperio, P. S., Shahoumian, T. A., Mole, L. A., & Backus, L. I. (2017) · Hepatology · doi:10.1002/hep.29135 · Cited by 135
Mahajan, R., Xing, J., Liu, S. J., Ly, K. N., Moorman, A. C., Rupp, L. B., Xu, F. Z., Holmberg, S. D., for the Chronic Hepatitis Cohort Study (CHeCS) Investigators, Holmberg, S. D., et al. (2014) · Clinical Infectious Diseases · doi:10.1093/cid/ciu077 · Cited by 124
Spradling, P. R., Xing, J., Rupp, L. B., Moorman, A. C., Gordon, S. C., Lü, M., Teshale, E. H., Boscarino, J. A., Schmidt, M. A., Daida, Y. G., et al. (2017) · Journal of Clinical Gastroenterology · doi:10.1097/mcg.0000000000000857 · Cited by 45
de la Flor, C., Porsa, E., & Nijhawan, A. E. (2017) · Public Health Reports · doi:10.1177/0033354917732755 · Cited by 42
Hepatitis C Virus Testing and Linkage to Care in North Carolina and South Carolina Jails, 2012–2014
Schoenbachler, B. T., Smith, B. D., Seña, A. C., Hilton, A., Bachman, S., Lunda, M., & Spaulding, A. C. (2016) · Public Health Reports · doi:10.1177/00333549161310s215 · Cited by 36
Akiyama, M. J., Kaba, F., Rosner, Z., Alper, H., Holzman, R. S., & MacDonald, R. S. (2016) · American Journal of Public Health · doi:10.2105/ajph.2016.303163 · Cited by 25
Five Questions Concerning Managing Hepatitis C in the Justice System
Spaulding, A. C., Adee, M. G., Lawrence, R., Chhatwal, J., & von Oehsen, W. H. (2018) · Infectious Disease Clinics of North America · doi:10.1016/j.idc.2018.02.014 · Cited by 20
Stockman, L. J., Greer, J., Holzmacher, R., Dittmann, B., Hoftiezer, S. A., Alsum, L. E., Prieve, A. F., Westergaard, R. P., Guilfoyle, S. M., & Vergeront, J. M. (2016) · Public Health Reports · doi:10.1177/0033354916662212 · Cited by 18
Cited by
Sexually Transmitted Infections Treatment Guidelines, 2021
Workowski, K. A., Bachmann, L. H., Chan, P. A., Johnston, C. M., Muzny, C. A., Park, I., Reno, H., Zenilman, J. M., & Bolan, G. A. (2021) · MMWR. Recommendations and Reports · doi:10.15585/mmwr.rr7004a1 · Cited by 3,018
Contemporary Epidemiology of Chronic Liver Disease and Cirrhosis
Moon, A. M., Singal, A. G., & Tapper, E. B. (2020) · Clinical Gastroenterology and Hepatology · doi:10.1016/j.cgh.2019.07.060 · Cited by 1,150
CDC Recommendations for Hepatitis C Screening Among Adults — United States, 2020
Schillie, S., Wester, C., Osborne, M., Wesolowski, L., & Ryerson, A. B. (2020) · MMWR. Recommendations and Reports · doi:10.15585/mmwr.rr6902a1 · Cited by 558
Self-citationAnnual Report to the Nation on the Status of Cancer, Part 1: National Cancer Statistics
Islami, F., Ward, E. M., Sung, H., Cronin, K. A., Tangka, F. K. L., Sherman, R. L., Zhao, J., Anderson, R. N., Henley, S. J., Yabroff, K. R., et al. (2021) · JNCI: Journal of the National Cancer Institute · doi:10.1093/jnci/djab131 · Cited by 478
Global Elimination of Chronic Hepatitis
Thomas, D. L. (2019) · New England Journal of Medicine · doi:10.1056/nejmra1810477 · Cited by 325
Metadata
- Authors
- Hofmeister, M. G., Rosenthal, E. M., Barker, L. K., Rosenberg, E. S., Barranco, M. A., Hall, E. W., Edlin, B. R., Mermin, J., Ward, J. W., & Ryerson, A. B.
- Venue
- Hepatology
- Published
- 2018-11-06
- Volume
- 69
- Issue
- 3
- Pages
- 1020-1031
- ISSN
- 0270-9139 (ISSN-L)
- 1527-3350
- OpenAlex
- W2900195724
- Cited by
- 486
- References
- 31
- FWCI
- 32.67
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.